"A Multicenter Ablate and Resect Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers"

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

August 31, 2021

Conditions
Malignant Tumor
Interventions
DEVICE

Novilase Interstitial Laser Therapy

Image guided Interstitial Laser Ablation of breast tumors

Trial Locations (12)

10032

Columbia University Medical Center - Department of Surgery, New York

20889

Walter Reed National Military Medical Center, Bethesda

43614

University of Toledo - Eleanor N. Dana Cancer Center Breast Care, Toledo

53226

Wheaton Franciscan Health System, Wauwatosa

60068

Advocate Lutheran General Hospital - Caldwell Breast Center, Park Ridge

60103

St. Alexius Breast Care of St. Alexius Medical Center, Bartlett

73126

University of Oklahoma Health Sciences Center, Oklahoma City

80220

Rose Medical Center - Rose Breast Center, Denver

85712

The Breast Center of Southern Arizona, Tucson

BS10 5NB

North Bristol NHS Trust: Southmead Hospital - The Breast Care Centre, Bristol

CM1 7ET

Mid Essex Hospital Services NHS Trust: Broomfield Hospital - Breast Unit, Chelmsford

NR4 7UY

Norfolk & Norwich University NHS Foundation Trusts: Norfolk and Norwich University Hospital, Norwich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novian Health Inc.

INDUSTRY

NCT01478438 - "A Multicenter Ablate and Resect Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers" | Biotech Hunter | Biotech Hunter